Alzheimer; News from the web:
Good news, the drug industry is not giving up on Alzheimer’s drugs despite lack of results so far. Would it be greed or their passion to help? Who knows but it is good news.
Read all about it HERE
Alzheimer; News from the web:
Good news, the drug industry is not giving up on Alzheimer’s drugs despite lack of results so far. Would it be greed or their passion to help? Who knows but it is good news.
Read all about it HERE
Alzheimer; News from the web:
Jalisco gene mutation causes early-onset Alzheimer’s. There is only 1 percent of Alzheimer’s patients who have genetic mutations known to cause the disease.
Read all about it HERE
Alzheimer; News from the web:
Scientists report that a novel small-molecule drug, which works by stopping toxic ion flow in the brain that is known to trigger neuronal apoptosis, can restore brain function and memory in a mouse model of Alzheimer’s disease (AD). The team believes the drug could be used to treat AD and other neurodegenerative diseases such as Parkinson’s and amyotropic lateral sclerosis (ALS).
Read all about it HERE
Alzheimer; News from the web:
You would think that all would be working cooperatively towards a solution for Alzheimer’s but this is not the case. The ridiculous costs and time that it takes to run effective tests lead to a short time to recoup your research costs when you would find a workable solution. Researchers can not make a good case that this is a wise investment for Pharmaceutical companies.
So something is really wrong here and the government should look into this.
Read all about it HERE
Alzheimer; News from the web:
Buildups of “clumpy” proteins in the brain are well-known hallmarks of Alzheimer’s, but not everyone who has them goes on to develop this neurodegenerative disease. Why is that? New research investigates.
Read all about it HERE
Alzheimer; News from the web:
Dr. Debbie Toiber, of the BGU Department of Life Sciences, and her team discovered that a specific protein — Sirtuin-6 (SIRT6) — is severely reduced in the brains of Alzheimer’s patients. SIRT6 is critical to the repair of DNA, the deterioration of which “is the beginning of the chain that ends in neurodegenerative diseases in seniors,” she explains.
The blood-brain barrier prevents us from simply being able to inject the protein into the brain to replenish its supply. Dr. Toiber is currently working on finding a way to increase the expression of the protein into the brain.
Read all about it HERE